Trackinsight Enterprise, a unified platform for institutional ETF research, analytics, and compliance, is now live. Explore Trackinsight Enterprise →

Help us improve your experience. Please confirm your investor type:

Compare ETFs Easily

The Ultimate ETF Comparison Tool - Try Now!

Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.

ETF IssuersInvescoPSCH
PSCH

Invesco S&P SmallCap Health Care ETF

Passive ETFEquity

The PSCH Exchange Traded Fund (ETF) is provided by Invesco. It is built to track an index: S&P SmallCap 600 Capped Health Care Index. The PSCH ETF provides physical exposure, so by buying it you actually own parts of all the 69 underlying holdings. This share class generates a stream of income by distributing dividends.

Advertisement

Advertisement

$54.65
-$0.79 (-1.42%) 3 days ago
1:30 PM 08/28/26 Closed
1D price range
$54.65$55.48
52W price range
$39.20$56.12
YTD Perf.
+23.86%
YTD Flows
Annualized volatility
Fund AuM
€159M
Share class AuM
€159M
TTM Yield
Tracking Error
Tracking Difference
ISIN
US46138E1495
TER
0.29%
Inception date
4/7/2010
Issuer
Replication method
Dividend policy
Compare similar ETFs
API
PerformanceDec 31, 2025 - Aug 28, 2026
-10%0%10%20%30%JANMARMAYJUL
Flows
Join for free to unlock
Data as of 07/31/26
Healthcare
100.00%
Latest PSCH news

No content available for this fund

FAQ about PSCH

PSCH is a Passive ETF. This ETF provides exposure to Small Cap US Health Care Equities.
PSCH tracks the S&P SmallCap 600 Capped Health Care Total Return Index - USD, through a full replication replication method.
PSCH carries a total expense ratio (TER) of 0.29%, indicating the annual cost for holding the fund.
PSCH was introduced to the market on April 7, 2010. It trades on United States
Invesco S&P SmallCap Health Care ETF, PSCH, is provided by Invesco. Learn more about Invesco here.
PSCH oversees €159M in assets as of August 28, 2026.
PSCH follows a distributing dividend policy, meaning it pays out income to investors. As of August 28, 2026, its 12-month trailing yield was 0.00%.
As of July 31, 2026, PSCH has significant geographic allocations in USA and Ireland.
As of July 31, 2026, PSCH focuses largely on Healthcare.
As of July 31, 2026, PSCH holds 69 positions in its portfolio, with 48.10% of assets concentrated in its top 15 holdings.
As of July 31, 2026, PSCH top three holdings include Glaukos Corp., Corcept Therapeutics, Inc. and Alkermes Plc.
The base currency of PSCH is USD.
Data as of 07/31/26
Glaukos Corp.
4.96%
Corcept Therapeutics, Inc.
4.64%
Alkermes Plc
4.21%
Protagonist Therapeutics, Inc.
4.20%
TG Therapeutics, Inc.
3.68%
PTC Therapeutics, Inc.
3.23%
Liquidia Corp.
3.19%
Teleflex, Inc.
3.11%
Ligand Pharmaceuticals, Inc.
3.01%
Indivior Pharmaceuticals, Inc.
2.55%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight